Back
NYLI Hedge Multi-Strategy Tracker ETF Vs. Collegium Pharmaceutical, Inc. Industry Stock Comparison
Buy
65
QAI
NYLI Hedge Multi-Strategy Tracker ETF
Last Price:
$34.03
Seasonality Move:
0.79%
Buy
73
COLL
Collegium Pharmaceutical, Inc.
Last Price:
$48.75
Seasonality Move:
7.64%
Buy
65
NYLI Hedge Multi-Strategy Tracker ETF (QAI)
is a Buy
Is NYLI Hedge Multi-Strategy Tracker ETF a Buy, Sell or Hold?
-
The current NYLI Hedge Multi-Strategy Tracker ETF [QAI] share price is $34.04. The Score for QAI is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
QAI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Collegium Pharmaceutical, Inc. (COLL)
is a Buy
Is Collegium Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical, Inc. [COLL] share price is $48.88. The Score for COLL is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
COLL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QAI Stock Price Chart
What is NYLI Hedge Multi-Strategy Tracker ETF's stock price today?
-
The NYLI Hedge Multi-Strategy Tracker ETF share price today is $34.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QAI is experiencing buying pressure, which is a positive indicator for future bullish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical, Inc.'s stock price today?
-
The Collegium Pharmaceutical, Inc. share price today is $48.88The current trend is moderately bullish and COLL is experiencing slight selling pressure.
QAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.38 | Buy |
| Relative Strength Index (14 RSI): | 59.16 | Buy |
| Chaikin Money Flow: | 31090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.46 - 33.98) | Buy |
| Bollinger Bands (100): | (33.05 - 33.91) | Buy |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 67.26 | Buy |
| Chaikin Money Flow: | -386781 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.54 - 48.66) | Buy |
| Bollinger Bands (100): | (33.41 - 44.57) | Buy |
QAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.94 | Buy |
| 20-day SMA: | 33.81 | Buy |
| 50-day SMA: | 33.76 | Buy |
| 200-day SMA: | 32.59 | Buy |
| 8-day EMA: | 17.96 | Buy |
| 20-day EMA: | 8.79 | Buy |
| 50-day EMA: | 3.83 | Buy |
| 200-day EMA: | 1 | Buy |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.84 | Buy |
| 20-day SMA: | 47.62 | Buy |
| 50-day SMA: | 42 | Buy |
| 200-day SMA: | 34.18 | Buy |
| 8-day EMA: | 48.68 | Buy |
| 20-day EMA: | 47.31 | Buy |
| 50-day EMA: | 43.1 | Buy |
| 200-day EMA: | 25.65 | Buy |
NYLI Hedge Multi-Strategy Tracker ETF Earnings Growth & QAI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical, Inc. Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.54 per share.
NYLI Hedge Multi-Strategy Tracker ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||